542678

Cian Healthcare Limited's Board of Directors met on May 30, 2026, and approved seeking shareholder approval via postal ballot for several items. These include approving material related party transactions, giving power to dispose of the undertaking, enhancing borrowing and investment limits, giving loans/guarantees, and the appointments of Mr. Rajesh Jain as Managing Director and Ms. Simmi Soni as Woman Non-Executive Director. The remote e-voting period is from June 10, 2026, to July 09, 2026.

The Board approved Audited Standalone and Consolidated Financial Results for the financial year ended March 31, 2026. Auditors issued a **modified opinion** on standalone results due to a severe lack of sufficient audit evidence for key accounts including trade receivables, PPE, inventory valuation, GST reconciliation, Expected Credit Loss provisions, internal financial controls, and audit trail. The company underwent Corporate Insolvency Resolution Process (CIRP) with a resolution plan approved on December 18, 2025. Furthermore, its wholly-owned subsidiary is also in CIRP with halted operations, and its auditor issued a **disclaimer of opinion**, leading the consolidated auditor to *not express an opinion* on the subsidiary's financial data for consolidation.

Cian Healthcare Limited announced its Audited Financial Results for the year ended March 31, 2026. The auditors issued a modified opinion on standalone results due to unconfirmed balances, lack of asset verification, inventory revaluation issues during the company's prior Corporate Insolvency Resolution Process (CIRP), and insufficient audit evidence. For consolidated results, the auditors issued a disclaimer of opinion, citing the subsidiary's ongoing CIRP and halted operations, making them unable to express an opinion on the true and fair view of the financials.

Cian Healthcare Limited informed BSE that the Annual Secretarial Compliance Report for the financial year ended March 31, 2026, is not applicable to the company. This is due to its listing on the Small and Medium Enterprises (SME) Platform of BSE Limited, which provides an exemption under Regulation 15(2)(b) of the SEBI Listing Regulations.

Cian Healthcare Limited announced that its Board of Directors will meet on May 30, 2026, to consider and approve the audited standalone and consolidated financial results for the half year and financial year ended March 31, 2026. The trading window for designated persons is closed from April 1, 2026, until 48 hours post-results declaration.